Cambium Networks Announces Nasdaq Delisting

Rhea-AI Summary

Cambium Networks (NASDAQ: CMBM) received a Nasdaq Hearings Panel decision to delist its ordinary shares, dated March 25, 2026.

Trading in the company's shares will be suspended at the open on March 27, 2026. The company said it is considering requesting a review by the Nasdaq Listing and Hearing Review Council. Shares are expected to move to OTC Pink Limited and then the Expert Market, which may reduce liquidity, transparency and increase price volatility for investors.

Positive

• Option to seek review from Nasdaq Listing and Hearing Review Council
• Continued trading path: expected move to OTC Pink Limited preserves a market for shares

Negative

• Nasdaq delisting determined on March 25, 2026
• Trading suspension effective at open on March 27, 2026
• Market tier downgrade to OTC Pink Limited then Expert Market
• Investor impact: reduced liquidity, less transparency and greater price volatility

News Market Reaction – CMBM

-77.34% 14.6x vol

31 alerts

-77.34% News Effect

-82.4% Trough in 45 min

-$171M Valuation Impact

$49.99M Market Cap

14.6x Rel. Volume

On the day this news was published, CMBM declined 77.34%, reflecting a significant negative market reaction. Argus tracked a trough of -82.4% from its starting point during tracking. Our momentum scanner triggered 31 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $171M from the company's valuation, bringing the market cap to $49.99M at that time. Trading volume was exceptionally heavy at 14.6x the daily average, suggesting significant selling pressure.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Nasdaq delisting notice date: March 25, 2026 Trading suspension date: March 27, 2026 Prior panel decision date: December 3, 2025

3 metrics

Nasdaq delisting notice date March 25, 2026 Date Nasdaq Hearings Panel determined to delist ordinary shares

Trading suspension date March 27, 2026 Date trading on Nasdaq scheduled to be suspended at market open

Prior panel decision date December 3, 2025 Date of earlier Nasdaq Hearings Panel decision referenced in article

Market Reality Check

Price: $0.4010 Vol: Volume 715,864 is 2.23x t...

high vol

$0.4010 Last Close

Volume Volume 715,864 is 2.23x the 20-day average of 321,712, indicating elevated trading interest ahead of the delisting notice. high

Technical Shares at $1.77 are trading above the 200-day moving average of $1.22 despite a formal Nasdaq delisting decision.

Peers on Argus

While CMBM traded down 1.12% ahead of the delisting announcement, peers in the c...

2 Up

While CMBM traded down 1.12% ahead of the delisting announcement, peers in the communication equipment group flagged by momentum scanners, such as BOSC and SONM, were moving up, indicating a stock-specific reaction rather than a sector-wide move.

Historical Context

5 past events · Latest: Jan 14 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 14	Product/platform update	Positive	+3.3%	Announced NSE enhancements enabling static public IPv4 over VPN for LEO/LTE.
Dec 18	Nasdaq compliance, CFO	Positive	-1.9%	Partial compliance with minimum bid rule and interim CFO appointment.
Dec 05	Continued listing granted	Positive	+9.8%	Nasdaq panel granted continued listing subject to compliance milestones.
Dec 01	Additional deficiency letter	Negative	-13.1%	New Nasdaq staff letter on further periodic filing delinquencies.
Nov 18	Financial update	Positive	+1.1%	Provided Q3 2025 shipment and orders update with new product launches.

Pattern Detected

Nasdaq listing and compliance headlines have frequently driven meaningful moves, with negative regulatory updates tending to align with share price declines and positive listing outcomes supporting rallies.

Recent Company History

Over the last six months, Cambium’s news flow has centered on Nasdaq compliance and operational updates. Positive developments like continued listing on Dec 3, 2025 and a technical product update on Jan 14, 2026 coincided with gains, while additional deficiency letters and delisting determinations on Nov 25 and Oct 16, 2025 saw double-digit declines. Today’s formal delisting decision from Nasdaq extends that regulatory trajectory after earlier partial compliance and monitoring milestones.

Market Pulse Summary

The stock dropped -77.3% in the session following this news. A negative reaction despite prior exten...

Analysis

The stock dropped -77.3% in the session following this news. A negative reaction despite prior extensions would fit the pattern seen after earlier Nasdaq deficiency letters, where regulatory setbacks triggered notable declines. The confirmed delisting decision and shift toward OTC Pink and the Expert Market highlight structural liquidity and transparency risks. With trading already more active at 2.23x typical volume, volatility could remain elevated as holders reassess mandates and access, and as the company evaluates its limited review options with Nasdaq.

Key Terms

nasdaq hearings panel, delist, the nasdaq stock market, securities and exchange commission, +3 more

7 terms

nasdaq hearings panel regulatory

"received a notice from the Nasdaq Hearings Panel (the "Panel") that the Panel has"

A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.

delist regulatory

"the Panel has determined to delist the ordinary shares of Cambium Networks from"

Delist means a company’s shares are removed from a public stock exchange so they can no longer be bought or sold on that market. Think of it like a product being taken off a supermarket shelf: the stock becomes harder to find, often leads to less trading, wider price swings, and reduced transparency, which matters to investors because it can limit ability to sell, change the value of holdings, and signal regulatory or financial problems.

the nasdaq stock market regulatory

"ordinary shares of Cambium Networks from The Nasdaq Stock Market ("Nasdaq")"

The Nasdaq Stock Market is an electronic marketplace where investors buy and sell shares of publicly traded companies, often including many technology and growth-oriented firms. It matters because listing there creates a public price, liquidity and regulatory oversight — like a busy public market where buyers and sellers set value — and Nasdaq’s trading systems and listing standards affect how easily investors can trade shares and how companies raise capital.

securities and exchange commission regulatory

"periodic reports with the Securities and Exchange Commission."

A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.

otc pink limited tier financial

"expected to initially move to the OTC Pink Limited tier and then go into"

OTC Pink Limited Tier is a designation on the over-the-counter market for companies that provide only partial, often outdated, public information. It signals lower transparency and regulatory oversight than higher tiers, meaning financial details, audits, or regular disclosures may be missing or incomplete. Investors should treat these listings like buying an unvetted used item: potential for bargain opportunities exists, but the risk of surprises, fraud, or poor liquidity is significantly higher.

expert market financial

"Pink Limited tier and then go into the Expert Market. Investors may experience"

An expert market is a trading venue or segment where a designated professional or market maker actively runs the buying and selling process for certain securities, especially those that are complex or thinly traded. Like an auctioneer at a niche market who knows the products and keeps transactions flowing, the expert helps set fair prices and provide liquidity; for investors this affects how easily they can trade, the transparency of prices, and potential costs or risks when buying or selling.

periodic reports regulatory

"milestones set forth in the Decision by which the Company was to file certain periodic reports"

Regularly scheduled documents that a publicly traded company must provide to disclose its financial results, business operations, risks and significant events — like a report card showing revenue, profits, cash flow and key changes over a set period. Investors use these reports to judge a company's health and trends, compare performance over time, and make informed buy, hold or sell decisions; they act as a routine check-up for financial transparency.

AI-generated analysis. Not financial advice.

HOFFMAN ESTATES, Ill., March 26, 2026 /PRNewswire/ -- Cambium Networks Corporation ("Cambium Networks" or the "Company") (NASDAQ: CMBM), a leading global provider of networking solutions, announced today that on March 25, 2026, the Company received a notice from the Nasdaq Hearings Panel (the "Panel") that the Panel has determined to delist the ordinary shares of Cambium Networks from The Nasdaq Stock Market ("Nasdaq") due to the Company's failure to comply with the terms of the Panel's December 3, 2025 decision (the "Decision"). The Company had been granted a extension for continued listing on Nasdaq subject to the Company's adherence to certain milestones set forth in the Decision by which the Company was to file certain periodic reports with the Securities and Exchange Commission. Trading in the Company's ordinary shares will be suspended at the open of trading on March 27, 2026. 

The Company is considering whether it will request that the Nasdaq Listing and Hearing Review Council review this Decision. Trading in our ordinary shares is expected to initially move to the OTC Pink Limited tier and then go into the Expert Market. Investors may experience reduced liquidity, less transparency and greater price volatility on these markets.

About Cambium Networks

Cambium Networks enables service providers, enterprises, industrial organizations, and governments to deliver exceptional digital experiences, and device connectivity, with compelling economics. Our ONE Network platform simplifies management of Cambium Networks' wired and wireless broadband and network edge technologies. Our customers can focus more resources on managing their business rather than the network. We make connectivity that just works.

Forward-Looking Statements

This press release contains forward-looking statements, including, but not limited to statements relating to the trading of the Company's ordinary shares on the OTC market, as well as words such as "expects," "anticipates," "intends," "believes," "may," "should," "could," "would," and variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based upon the Company's current assumptions, beliefs, and expectations. Forward-looking statements are subject to the occurrence of many events outside of the Company's control. Actual results and the timing of events may differ materially from those contemplated by such forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things, the Company's trading on the OTC market, the ability to return to Nasdaq and maintain compliance with Nasdaq continued listing standards. Forward-looking statements should be considered in light of these risks and uncertainties. Investors and others are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements contained herein speak only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Contacts:
Investor Relations
Cambium Networks
investors@Cambiumnetworks.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cambium-networks-announces-nasdaq-delisting-302726208.html

SOURCE Cambium Networks

FAQ

Why did Nasdaq decide to delist Cambium Networks (CMBM) on March 25, 2026?

Nasdaq determined delisting due to failure to comply with milestones in the Panel's December 3, 2025 decision. According to the company, the delisting follows noncompliance with required periodic-report filing milestones set by the Panel.

When will trading of Cambium Networks (CMBM) be suspended on Nasdaq?

Trading will be suspended at the open of trading on March 27, 2026. According to the company, that suspension follows the Panel's March 25, 2026 delisting determination and precedes the expected move to OTC markets.

What market will Cambium Networks (CMBM) trade on after Nasdaq suspension?

Shares are expected to move to OTC Pink Limited and then the Expert Market. According to the company, this is the planned path following Nasdaq suspension and may affect trading conditions.

How might the Nasdaq delisting affect CMBM shareholders' liquidity and transparency?

Shareholders may face reduced liquidity and less transparency, increasing price volatility. According to the company, trading on OTC Pink Limited and Expert Market generally offers lower liquidity and disclosure than Nasdaq.

Can Cambium Networks (CMBM) challenge the Nasdaq delisting decision?

Yes, the company is considering requesting a review by the Nasdaq Listing and Hearing Review Council. According to the company, it may seek the Council's review of the Panel's decision as a next step.